We know Axxin developed a reader specifically for our covid test...
We also know this...
"The company says marketing plans and strategy for a platform launch and launch of the COVID-19 tests are well underway."
Does this mean the reader was also fine tuned for the COVID multiplex and Sepsis tests?
Which means we could be seeing these two tests in clinical trials much sooner than we expected?
Ellume 250,000 test per day by Mar 2021, page-134
-
- There are more pages in this discussion • 23 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $51.83M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.1¢ | $14.91K | 710.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 16 | 2379550 | 2.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 309108 | 3 |
View Market Depth
| Last trade - 11.49am 16/07/2024 (20 minute delay) ? |
| ADO (ASX) Chart |